Symbols / HSIC Stock $77.20 -0.44% Henry Schein, Inc.

Healthcare • Medical Distribution • United States • NMS
HSIC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Distribution
CEO Mr. Andrea Albertini
Exch · Country NMS · United States
Market Cap 8.86B
Enterprise Value 13.69B
Income 398.00M
Sales 13.18B
FCF (ttm) 383.00M
Book/sh 28.03
Cash/sh 1.36
Employees 25,000
Insider 10d —
IPO Nov 03, 1995
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 23.61
Forward P/E 13.12
PEG 1.72
P/S 0.67
P/B 2.75
P/C —
EV/EBITDA 13.38
EV/Sales 1.04
Quick Ratio 0.56
Current Ratio 1.38
Debt/Eq 71.74
LT Debt/Eq —
EPS (ttm) 3.27
EPS next Y 5.88
EPS Growth 13.60%
Revenue Growth 7.70%
EPS Gr Q/Q 7.40%
Rev Gr Q/Q —
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-24
ROA 4.33%
ROE 8.70%
ROIC —
Gross Margin 31.14%
Oper. Margin 5.30%
Profit Margin 3.02%
Shs Outstand 114.75M
Shs Float 94.90M
Insider Own 0.82%
Instit Own 106.60%
Short Float 6.82%
Short Ratio 6.22
Short Interest 6.50M
52W High 89.29
vs 52W High -13.54%
52W Low 61.95
vs 52W Low 24.62%
Beta 0.88
Impl. Vol. 1.56%
Rel Volume 0.86
Avg Volume 1.30M
Volume 1.12M
Target (mean) $90.21
Tgt Median $89.50
Tgt Low $64.00
Tgt High $104.00
# Analysts 14
Recom Buy
Prev Close $77.54
Price $77.20
Change -0.44%
About

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$90.21
Mean price target
2. Current target
$77.20
Latest analyst target
3. DCF / Fair value
$60.08
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$77.20
Low
$64.00
High
$104.00
Mean
$90.21

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-24 main Morgan Stanley Underweight → Underweight $64
2026-04-16 init BTIG — → Neutral —
2026-04-15 init Citigroup — → Buy $100
2026-04-08 main Evercore ISI Group Outperform → Outperform $90
2026-02-25 main Barrington Research Outperform → Outperform $97
2026-02-25 main UBS Neutral → Neutral $87
2026-02-25 main JP Morgan Overweight → Overweight $92
2026-02-25 main Mizuho Neutral → Neutral $88
2026-02-25 main Morgan Stanley Underweight → Underweight $61
2026-02-25 main Wells Fargo Equal-Weight → Equal-Weight $87
2026-02-25 main Evercore ISI Group Outperform → Outperform $100
2026-02-24 main Leerink Partners Market Perform → Market Perform $87
2026-02-23 up Baird Neutral → Outperform $100
2026-01-20 main Mizuho Neutral → Neutral $81
2025-12-09 init Barclays — → Overweight $86
2025-11-05 main JP Morgan Overweight → Overweight $78
2025-11-05 main Barrington Research Outperform → Outperform $79
2025-11-05 main Morgan Stanley Underweight → Underweight $58
2025-11-05 main Wells Fargo Equal-Weight → Equal-Weight $76
2025-11-05 main Evercore ISI Group Outperform → Outperform $90
News
RSS: Latest HSIC news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-19 POPECK THOMAS C Officer — 1,355 $72.79 $98,630
2026-03-17 ETTINGER MICHAEL S. Chief Operating Officer — 2,300 $0.00 $0
2026-03-16 BERGMAN STANLEY M Director — 400 $0.00 $0
2026-03-12 BERGMAN STANLEY M Director — 970 $0.00 $0
2026-03-10 KUEHN KURT P Director — 2,844 $78.96 $224,565
2026-03-06 HOMBACH ROBERT J. CPA Director — 2,577 $0.00 $0
2026-03-06 ALI MOHAMAD S Director — 2,577 $0.00 $0
2026-03-06 MARGULIES ANNE H Director — 2,577 $0.00 $0
2026-03-06 LOWERY FREDERICK M. Chief Executive Officer — 64,433 $0.00 $0
2026-03-06 DANIEL WILLIAM K Director — 2,577 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
13,184.00
+4.03%
12,673.00
+2.71%
12,339.00
-2.44%
12,647.00
Operating Revenue
13,184.00
+4.03%
12,673.00
+2.71%
12,339.00
-2.44%
12,647.00
Cost Of Revenue
9,079.00
+4.87%
8,657.00
+2.10%
8,479.00
-3.82%
8,816.00
Reconciled Cost Of Revenue
9,061.00
+4.87%
8,640.00
+2.06%
8,466.00
-3.84%
8,804.00
Gross Profit
4,105.00
+2.22%
4,016.00
+4.04%
3,860.00
+0.76%
3,831.00
Operating Expense
3,347.00
+1.89%
3,285.00
+3.79%
3,165.00
+7.18%
2,953.00
Selling General And Administration
3,084.00
+1.65%
3,034.00
+2.64%
2,956.00
+6.68%
2,771.00
Total Expenses
12,426.00
+4.05%
11,942.00
+2.56%
11,644.00
-1.06%
11,769.00
Operating Income
758.00
+3.69%
731.00
+5.18%
695.00
-20.84%
878.00
Total Operating Income As Reported
653.00
+5.15%
621.00
+0.98%
615.00
-17.67%
747.00
EBITDA
964.00
+5.70%
912.00
+7.17%
851.00
-10.42%
950.00
Normalized EBITDA
1,069.00
+4.60%
1,022.00
+9.77%
931.00
-13.88%
1,081.00
Reconciled Depreciation
281.00
+4.85%
268.00
+20.72%
222.00
+14.43%
194.00
EBIT
683.00
+6.06%
644.00
+2.38%
629.00
-16.80%
756.00
Total Unusual Items
-105.00
+4.55%
-110.00
-37.50%
-80.00
+38.93%
-131.00
Total Unusual Items Excluding Goodwill
-105.00
+4.55%
-110.00
-37.50%
-80.00
+38.93%
-131.00
Special Income Charges
-105.00
+4.55%
-110.00
-37.50%
-80.00
+38.93%
-131.00
Restructuring And Mergern Acquisition
105.00
-4.55%
110.00
+37.50%
80.00
-38.93%
131.00
Net Income
398.00
+2.05%
390.00
-6.25%
416.00
-22.68%
538.00
Pretax Income
533.00
+3.90%
513.00
-5.35%
542.00
-24.83%
721.00
Net Non Operating Interest Income Expense
-117.00
-9.35%
-107.00
-52.86%
-70.00
-159.26%
-27.00
Interest Expense Non Operating
150.00
+14.50%
131.00
+50.57%
87.00
+148.57%
35.00
Net Interest Income
-117.00
-9.35%
-107.00
-52.86%
-70.00
-159.26%
-27.00
Interest Expense
150.00
+14.50%
131.00
+50.57%
87.00
+148.57%
35.00
Interest Income Non Operating
33.00
+37.50%
24.00
+41.18%
17.00
+112.50%
8.00
Interest Income
33.00
+37.50%
24.00
+41.18%
17.00
+112.50%
8.00
Other Income Expense
-108.00
+2.70%
-111.00
-33.73%
-83.00
+36.15%
-130.00
Other Non Operating Income Expenses
-3.00
-200.00%
-1.00
+66.67%
-3.00
-400.00%
1.00
Tax Provision
126.00
-1.56%
128.00
+6.67%
120.00
-29.41%
170.00
Tax Rate For Calcs
0.00
-4.82%
0.00
+12.47%
0.00
-5.79%
0.00
Tax Effect Of Unusual Items
-24.89
+9.15%
-27.39
-54.64%
-17.71
+42.46%
-30.79
Net Income Including Noncontrolling Interests
419.00
+5.28%
398.00
-8.72%
436.00
-22.97%
566.00
Net Income From Continuing Operation Net Minority Interest
398.00
+2.05%
390.00
-6.25%
416.00
-22.68%
538.00
Net Income From Continuing And Discontinued Operation
398.00
+2.05%
390.00
-6.25%
416.00
-22.68%
538.00
Net Income Continuous Operations
419.00
+5.28%
398.00
-8.72%
436.00
-22.97%
566.00
Net Income Discontinuous Operations
—
—
—
0.00
Minority Interests
-21.00
-162.50%
-8.00
+60.00%
-20.00
+28.57%
-28.00
Normalized Income
478.12
+1.16%
472.61
-1.19%
478.29
-25.06%
638.22
Net Income Common Stockholders
398.00
+2.05%
390.00
-6.25%
416.00
-22.68%
538.00
Diluted EPS
—
3.05
-3.48%
3.16
-19.18%
3.91
Basic EPS
—
3.07
-3.46%
3.18
-19.49%
3.95
Basic Average Shares
—
126.79
-2.93%
130.62
-4.00%
136.06
Diluted Average Shares
—
127.78
-3.01%
131.75
-4.36%
137.76
Diluted NI Availto Com Stockholders
398.00
+2.05%
390.00
-6.25%
416.00
-22.68%
538.00
Depreciation Amortization Depletion Income Statement
263.00
+4.78%
251.00
+20.10%
209.00
+14.84%
182.00
Depreciation And Amortization In Income Statement
263.00
+4.78%
251.00
+20.10%
209.00
+14.84%
182.00
Earnings From Equity Interest Net Of Tax
12.00
-7.69%
13.00
-7.14%
14.00
-6.67%
15.00
Line Item Trend 2023-12-31
Total Assets
10,573.00
Current Assets
4,488.00
Cash Cash Equivalents And Short Term Investments
171.00
Cash And Cash Equivalents
171.00
Receivables
1,863.00
Accounts Receivable
1,863.00
Gross Accounts Receivable
1,946.00
Allowance For Doubtful Accounts Receivable
-83.00
Inventory
1,815.00
Prepaid Assets
—
Other Current Assets
639.00
Total Non Current Assets
6,085.00
Net PPE
823.00
Gross PPE
1,495.00
Accumulated Depreciation
-672.00
Properties
0.00
Land And Improvements
21.00
Buildings And Improvements
166.00
Machinery Furniture Equipment
880.00
Other Properties
325.00
Leases
103.00
Goodwill And Other Intangible Assets
4,791.00
Goodwill
3,875.00
Other Intangible Assets
916.00
Investments And Advances
180.00
Long Term Equity Investment
180.00
Non Current Deferred Assets
133.00
Non Current Deferred Taxes Assets
38.00
Non Current Prepaid Assets
4.00
Other Non Current Assets
101.00
Total Liabilities Net Minority Interest
5,420.00
Current Liabilities
2,683.00
Payables And Accrued Expenses
2,189.00
Payables
1,157.00
Accounts Payable
1,020.00
Current Accrued Expenses
1,032.00
Total Tax Payable
137.00
Current Debt And Capital Lease Obligation
494.00
Current Debt
414.00
Other Current Borrowings
150.00
Current Capital Lease Obligation
80.00
Total Non Current Liabilities Net Minority Interest
2,737.00
Long Term Debt And Capital Lease Obligation
2,247.00
Long Term Debt
1,937.00
Long Term Capital Lease Obligation
310.00
Defined Pension Benefit
9.00
Non Current Deferred Liabilities
54.00
Non Current Deferred Taxes Liabilities
54.00
Other Non Current Liabilities
436.00
Preferred Securities Outside Stock Equity
—
Stockholders Equity
3,655.00
Common Stock Equity
3,655.00
Capital Stock
1.00
Common Stock
1.00
Preferred Stock
0.00
Share Issued
129.25
Ordinary Shares Number
129.25
Treasury Shares Number
0.00
Additional Paid In Capital
0.00
Retained Earnings
3,860.00
Gains Losses Not Affecting Retained Earnings
-206.00
Minority Interest
1,498.00
Other Equity Adjustments
-206.00
Total Equity Gross Minority Interest
5,153.00
Total Capitalization
5,592.00
Working Capital
1,805.00
Invested Capital
6,006.00
Total Debt
2,741.00
Net Debt
2,180.00
Capital Lease Obligations
390.00
Net Tangible Assets
-1,136.00
Tangible Book Value
-1,136.00
Investmentsin Associatesat Cost
—
Line Of Credit
264.00
Non Current Note Receivables
44.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
712.00
-16.04%
848.00
+69.60%
500.00
-16.94%
602.00
Cash Flow From Continuing Operating Activities
712.00
-16.04%
848.00
+69.60%
500.00
-16.94%
602.00
Cash From Discontinued Operating Activities
—
—
—
0.00
Net Income From Continuing Operations
419.00
+5.28%
398.00
-8.72%
436.00
-22.97%
566.00
Depreciation Amortization Depletion
281.00
+4.85%
268.00
+20.72%
222.00
+14.43%
194.00
Depreciation
101.00
+21.69%
83.00
+18.57%
70.00
+2.94%
68.00
Amortization Cash Flow
180.00
-2.70%
185.00
+21.71%
152.00
+20.63%
126.00
Depreciation And Amortization
281.00
+4.85%
268.00
+20.72%
222.00
+14.43%
194.00
Amortization Of Intangibles
180.00
-2.70%
185.00
+21.71%
152.00
+20.63%
126.00
Other Non Cash Items
-49.00
-1080.00%
5.00
-79.17%
24.00
-67.12%
73.00
Stock Based Compensation
39.00
+0.00%
39.00
+0.00%
39.00
-27.78%
54.00
Provisionand Write Offof Assets
16.00
+14.29%
14.00
-22.22%
18.00
+260.00%
5.00
Asset Impairment Charge
16.00
+33.33%
12.00
-64.71%
34.00
+0.00%
34.00
Deferred Tax
9.00
+116.07%
-56.00
-460.00%
-10.00
+83.61%
-61.00
Deferred Income Tax
9.00
+116.07%
-56.00
-460.00%
-10.00
+83.61%
-61.00
Operating Gains Losses
-12.00
+7.69%
-13.00
+7.14%
-14.00
+6.67%
-15.00
Change In Working Capital
-48.00
-134.29%
140.00
+148.28%
-290.00
-3.20%
-281.00
Change In Receivables
-124.00
-139.37%
315.00
+196.33%
-327.00
-4571.43%
-7.00
Changes In Account Receivables
-124.00
-139.37%
315.00
+196.33%
-327.00
-4571.43%
-7.00
Change In Inventory
-95.00
-61.02%
-59.00
-125.54%
231.00
+283.33%
-126.00
Change In Payables And Accrued Expense
216.00
+232.52%
-163.00
-191.07%
-56.00
+41.67%
-96.00
Change In Other Current Assets
-45.00
-195.74%
47.00
+134.06%
-138.00
-165.38%
-52.00
Investing Cash Flow
-400.00
+6.98%
-430.00
+62.11%
-1,135.00
-311.23%
-276.00
Cash Flow From Continuing Investing Activities
-400.00
+6.98%
-430.00
+62.11%
-1,135.00
-311.23%
-276.00
Cash From Discontinued Investing Activities
—
—
—
—
Net PPE Purchase And Sale
-139.00
+6.08%
-148.00
-0.68%
-147.00
-53.13%
-96.00
Purchase Of PPE
-139.00
+6.08%
-148.00
-0.68%
-147.00
-53.13%
-96.00
Capital Expenditure
-191.00
-2.14%
-187.00
+0.00%
-187.00
-46.09%
-128.00
Capital Expenditure Reported
-52.00
-33.33%
-39.00
+2.50%
-40.00
-25.00%
-32.00
Net Investment Purchase And Sale
0.00
0.00
-100.00%
22.00
0.00
Sale Of Investment
0.00
0.00
-100.00%
22.00
0.00
Net Business Purchase And Sale
-199.00
+13.48%
-230.00
+75.92%
-955.00
-504.43%
-158.00
Purchase Of Business
-199.00
+13.48%
-230.00
+75.92%
-955.00
-504.43%
-158.00
Gain Loss On Sale Of Business
—
—
—
0.00
Net Other Investing Changes
-10.00
+23.08%
-13.00
+13.33%
-15.00
-250.00%
10.00
Financing Cash Flow
-188.00
+63.14%
-510.00
-172.75%
701.00
+322.54%
-315.00
Cash Flow From Continuing Financing Activities
-188.00
+63.14%
-510.00
-172.75%
701.00
+322.54%
-315.00
Net Issuance Payments Of Debt
553.00
+192.59%
189.00
-82.05%
1,053.00
+306.56%
259.00
Issuance Of Debt
489.00
+307.50%
120.00
-91.23%
1,368.00
+406.67%
270.00
Repayment Of Debt
-44.00
+86.16%
-318.00
+32.05%
-468.00
-693.22%
-59.00
Long Term Debt Issuance
489.00
+307.50%
120.00
-91.23%
1,368.00
+406.67%
270.00
Long Term Debt Payments
-44.00
+86.16%
-318.00
+32.05%
-468.00
-693.22%
-59.00
Net Long Term Debt Issuance
445.00
+324.75%
-198.00
-122.00%
900.00
+326.54%
211.00
Net Short Term Debt Issuance
108.00
-72.09%
387.00
+152.94%
153.00
+218.75%
48.00
Net Common Stock Issuance
-600.00
-55.84%
-385.00
-54.00%
-250.00
+48.45%
-485.00
Common Stock Payments
-850.00
-120.78%
-385.00
-54.00%
-250.00
+48.45%
-485.00
Repurchase Of Capital Stock
-850.00
-120.78%
-385.00
-54.00%
-250.00
+48.45%
-485.00
Proceeds From Stock Option Exercised
2.00
-66.67%
6.00
+500.00%
1.00
-50.00%
2.00
Net Other Financing Charges
-143.00
+55.31%
-320.00
-210.68%
-103.00
-13.19%
-91.00
Changes In Cash
124.00
+234.78%
-92.00
-239.39%
66.00
+500.00%
11.00
Effect Of Exchange Rate Changes
-90.00
-309.30%
43.00
+458.33%
-12.00
+0.00%
-12.00
Beginning Cash Position
122.00
-28.65%
171.00
+46.15%
117.00
-0.85%
118.00
End Cash Position
156.00
+27.87%
122.00
-28.65%
171.00
+46.15%
117.00
Free Cash Flow
521.00
-21.18%
661.00
+111.18%
313.00
-33.97%
474.00
Interest Paid Supplemental Data
151.00
+14.39%
132.00
+57.14%
84.00
+78.72%
47.00
Income Tax Paid Supplemental Data
—
144.00
-33.94%
218.00
-17.74%
265.00
Amortization Of Securities
30.00
+3.45%
29.00
+11.54%
26.00
+44.44%
18.00
Common Stock Issuance
250.00
0.00
0.00
—
Dividend Received CFO
11.00
-8.33%
12.00
-20.00%
15.00
+0.00%
15.00
Earnings Losses From Equity Investments
-12.00
+7.69%
-13.00
+7.14%
-14.00
+6.67%
-15.00
Issuance Of Capital Stock
250.00
0.00
0.00
—
Sale Of Business
—
—
0.00
0.00
Cash From Discontinued Financing Activities
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category